Literature DB >> 26820486

Adjusting the QRS Duration by Body Mass Index for Prediction of Response to Cardiac Resynchronization Therapy: Does One QRS Size Fit All?

Oguz Karaca1, Mehmet O Omaygenc1, Beytullah Cakal1, Sinem D Cakal1, Haci M Gunes1, Erkam Olgun1, Ersin Ibisoglu1, Umeyir Savur1, Tayyar Gokdeniz1, Bilal Boztosun1, Fethi Kilicaslan1.   

Abstract

BACKGROUND: QRS duration (QRSd) is known to be affected by body weight and length. We tested the hypothesis that adjusting the QRSd by body mass index (BMI) may provide individualization for patient selection and improve prediction of cardiac resynchronization therapy (CRT) response.
METHODS: A total of 125 CRT recipients was analyzed to assess functional (≥1 grade reduction in NYHA class) and echocardiographic (≥15% reduction in LVESV) response to CRT at 6 months of implantation. Baseline QRSd was adjusted by BMI to create a QRS index (QRSd/BMI) and tested for prediction of CRT response in comparison to QRSd.
RESULTS: Overall, 81 patients (65%) responded to CRT volumetrically. The mean QRS index was higher in CRT responders compared to nonresponders (6.2 ± 1.1 vs 5.2 ± 0.8 ms.m(2) /kg, P < 0.001). There was a positive linear correlation between the QRS index and the change in LVESV (r = 0.487, P < 0.001). Patients with a high QRS index (≥5.5 ms.m(2) /kg, derived from the ROC analysis, AUC = 0.787) compared to those with a prolonged QRSd (≥150 ms, AUC = 0.729) had a greater functional (72% vs 28%, P < 0.001) and echocardiographic (80% vs 44%, P < 0.001) improvement at 6 months. QRS index predicted CRT response at regression analysis.
CONCLUSIONS: Indexing the QRSd by BMI improves patient selection for CRT by eliminating the influence of body weight and length on QRSd. QRS index is a novel indicator that provides promising results for prediction of CRT response.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  CRT response; QRS duration; QRS index; cardiac resynchronization therapy

Mesh:

Year:  2016        PMID: 26820486      PMCID: PMC6931513          DOI: 10.1111/anec.12346

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  21 in total

1.  2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).

Authors:  Michele Brignole; Angelo Auricchio; Gonzalo Baron-Esquivias; Pierre Bordachar; Giuseppe Boriani; Ole-A Breithardt; John Cleland; Jean-Claude Deharo; Victoria Delgado; Perry M Elliott; Bulent Gorenek; Carsten W Israel; Christophe Leclercq; Cecilia Linde; Lluís Mont; Luigi Padeletti; Richard Sutton; Panos E Vardas
Journal:  Europace       Date:  2013-06-24       Impact factor: 5.214

2.  Cardiac resynchronization therapy restored ventricular septal myocardial perfusion and enhanced ventricular remodeling in patients with nonischemic cardiomyopathy presenting with left bundle branch block.

Authors:  Michio Ogano; Yu-Ki Iwasaki; Jun Tanabe; Hisato Takagi; Takuya Umemoto; Meiso Hayashi; Yasushi Miyauchi; Wataru Shimizu
Journal:  Heart Rhythm       Date:  2014-02-19       Impact factor: 6.343

Review 3.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Authors:  Roberto M Lang; Luigi P Badano; Victor Mor-Avi; Jonathan Afilalo; Anderson Armstrong; Laura Ernande; Frank A Flachskampf; Elyse Foster; Steven A Goldstein; Tatiana Kuznetsova; Patrizio Lancellotti; Denisa Muraru; Michael H Picard; Ernst R Rietzschel; Lawrence Rudski; Kirk T Spencer; Wendy Tsang; Jens-Uwe Voigt
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-03       Impact factor: 6.875

4.  Usefulness of notched duration to predict response to cardiac resynchronization therapy.

Authors:  Mustafa Mücahit Balci; Kevser Gülcihan Balci; Fatih Sen; Orhan Maden; Sefa Unal; Mehmet Timur Selcuk; Hatice Selcuk
Journal:  Scand Cardiovasc J       Date:  2015-05-07       Impact factor: 1.589

5.  Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group.

Authors:  A Auricchio; C Stellbrink; M Block; S Sack; J Vogt; P Bakker; H Klein; A Kramer; J Ding; R Salo; B Tockman; T Pochet; J Spinelli
Journal:  Circulation       Date:  1999-06-15       Impact factor: 29.690

6.  Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay.

Authors:  S Cazeau; C Leclercq; T Lavergne; S Walker; C Varma; C Linde; S Garrigue; L Kappenberger; G A Haywood; M Santini; C Bailleul; J C Daubert
Journal:  N Engl J Med       Date:  2001-03-22       Impact factor: 91.245

7.  Cross-sectional relations of electrocardiographic QRS duration to left ventricular dimensions: the Framingham Heart Study.

Authors:  Ravi Dhingra; Byung Ho Nam; Emelia J Benjamin; Thomas J Wang; Martin G Larson; Ralph B D'Agostino; Daniel Levy; Ramachandran S Vasan
Journal:  J Am Coll Cardiol       Date:  2005-03-01       Impact factor: 24.094

8.  Left ventricular lead position for cardiac resynchronization: a comprehensive cinegraphic, echocardiographic, clinical, and survival analysis.

Authors:  Ying-Xue Dong; Brian D Powell; Samuel J Asirvatham; Paul A Friedman; Robert F Rea; Tracy L Webster; Kelly L Brooke; David O Hodge; Heather J Wiste; Yan-Zong Yang; David L Hayes; Yong-Mei Cha
Journal:  Europace       Date:  2012-03-30       Impact factor: 5.214

9.  Adjusting the QRS Duration by Body Mass Index for Prediction of Response to Cardiac Resynchronization Therapy: Does One QRS Size Fit All?

Authors:  Oguz Karaca; Mehmet O Omaygenc; Beytullah Cakal; Sinem D Cakal; Haci M Gunes; Erkam Olgun; Ersin Ibisoglu; Umeyir Savur; Tayyar Gokdeniz; Bilal Boztosun; Fethi Kilicaslan
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-01-28       Impact factor: 1.468

Review 10.  An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure.

Authors:  John G Cleland; William T Abraham; Cecilia Linde; Michael R Gold; James B Young; J Claude Daubert; Lou Sherfesee; George A Wells; Anthony S L Tang
Journal:  Eur Heart J       Date:  2013-07-29       Impact factor: 29.983

View more
  4 in total

1.  Adjusting the QRS Duration by Body Mass Index for Prediction of Response to Cardiac Resynchronization Therapy: Does One QRS Size Fit All?

Authors:  Oguz Karaca; Mehmet O Omaygenc; Beytullah Cakal; Sinem D Cakal; Haci M Gunes; Erkam Olgun; Ersin Ibisoglu; Umeyir Savur; Tayyar Gokdeniz; Bilal Boztosun; Fethi Kilicaslan
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-01-28       Impact factor: 1.468

2.  Electroanatomic Ratios and Mortality in Patients With Heart Failure: Insights from the ASIAN-HF Registry.

Authors:  Janice Y Chyou; Wan Ting Tay; Inder S Anand; Tiew-Hwa Katherine Teng; Jonathan J L Yap; Michael R MacDonald; Vijay Chopra; Seet Yoong Loh; Wataru Shimizu; Imran Zainal Abidin; Arthur Mark Richards; Javed Butler; Carolyn S P Lam
Journal:  J Am Heart Assoc       Date:  2021-03-13       Impact factor: 5.501

3.  Narrower QRS may be enough to respond to cardiac resynchronization therapy in lightweight patients.

Authors:  Toshiko Nakai; Hiroaki Mano; Yukitoshi Ikeya; Yoshihiro Aizawa; Sayaka Kurokawa; Kimie Ohkubo; Koichi Nagashima; Ichiro Watanabe; Yasuo Okumura
Journal:  Heart Vessels       Date:  2019-11-27       Impact factor: 2.037

4.  Association between changes in QRS width and echocardiographic responses to cardiac resynchronization therapy: A systematic review and meta-analysis.

Authors:  Jing Ma; Yi Liu; Yun Dong; Ming Chen; Lianghua Xia; Min Xu
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.